Opus Genetics Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, Opus Genetics stock has a consensus rating of "Strong Buy" and an average price target of $10.44. The average 1-year stock price forecast is 156.51% higher than the current stock price, while the lowest is $8.00 (+96.56%) and the highest is $16 (+293.12%).

Price Target: $10.44 (+156.51%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$8.00	$10.44	$10	$16
Change	+96.56%	+156.51%	+145.70%	+293.12%

Analyst Ratings

The average analyst rating for Opus Genetics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	10	11	13	13	14	14
Buy	1	1	1	2	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	12	14	15	16	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Daniil Gataulin Chardan Capital	Chardan Capital	Buy Maintains $11 → $13	Buy	Maintains	$11 → $13	+219.41%	Jun 18, 2026
Albert Lowe Craig-Hallum	Craig-Hallum	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Jun 18, 2026
Francois Brisebois LifeSci Capital	LifeSci Capital	Buy Reiterates $9 → $10	Buy	Reiterates	$9 → $10	+145.70%	Jun 17, 2026
Kostas Biliouris Oppenheimer	Oppenheimer	Buy Reiterates $10	Buy	Reiterates	$10	+145.70%	Jun 17, 2026
Yun Zhong Wedbush	Wedbush	Buy Maintains $10	Buy	Maintains	$10	+145.70%	Jun 17, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

14.69M

from 14.20M

3.49%

from 14.20M

Revenue Next Year

14.81M

from 14.69M

0.78%

from 14.69M

EPS This Year

-0.97

from -0.80

EPS Next Year

-0.71

from -0.97

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	589.00K	39.85M	19.05M	10.99M	14.20M	14.69M
Revenue Growth	-	6,665.71%	-52.20%	-42.30%	29.15%	3.49%
Gross Profit	-14.58M	25.50M	1.40M	-15.86M	-16.62M	14.69M
Gross Margin	-2,476.06%	63.98%	7.33%	-144.28%	-117.05%	100.00%
Operating Income	-22.71M	18.23M	-10.56M	-34.07M	-38.60M	-52.49M
Net Income	-56.69M	17.89M	-9.99M	-57.53M	-49.59M	-94.53M
EPS	-	-	-	-	-0.80	-0.97
Free Cash Flow	-12.29M	7.64M	244.13K	-13.53M	-23.77M	-49.39M
No. Analysts	-	-	-	-	-	15

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	27.3M
Avg	14.7M
Low	2.2M

Revenue Growth

Revenue Growth	2026	2027	2028
High	92.2%
Avg	3.5%
Low	-84.5%

EPS Forecast

EPS	2026	2027	2028
High	-0.20
Avg	-0.97
Low	-1.31

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-